Literature DB >> 26407269

Piperacillin-Tazobactam Usage at a Tertiary Pediatric Hospital: An Antimicrobial Stewardship Review.

Andrew B Janowski1, Marian G Michaels2, Judith M Martin2, Michael D Green2.   

Abstract

In this review of 200 charts, piperacillin-tazobactam usage was analyzed at a pediatric tertiary hospital, with an assessment of the indications for initiation, and continuation at day 3 of usage. Significant cost savings could be obtained with antibiotic stewardship audit on day 3 of antibiotic administration.
© The Author 2015. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  antimicrobial stewardship; de-escalation; piperacillin/tazobactam

Mesh：

Substances：

Year:  2015        PMID： 26407269      PMCID： PMC6281135          DOI： 10.1093/jpids/piv036

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN： 2048-7193            Impact factor:   3.164


  12 in total

1.  Appropriate use of restricted antimicrobial agents in hospitals: the importance of empirical therapy and assisted re-evaluation.

Authors:  M Thuong; F Shortgen; V Zazempa; E Girou; C J Soussy; C Brun-Buisson
Journal:  J Antimicrob Chemother       Date:  2000-09       Impact factor: 5.790

Review 2.  Antimicrobial stewardship--the state of the art in 2011: focus on outcome and methods.

Authors:  John E McGowan
Journal:  Infect Control Hosp Epidemiol       Date:  2012-04       Impact factor: 3.254

3.  Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS).

Authors: 
Journal:  Infect Control Hosp Epidemiol       Date:  2012-04       Impact factor: 3.254

Review 4.  Antibiotic de-escalation.

Authors:  Robert G Masterton
Journal:  Crit Care Clin       Date:  2011-01       Impact factor: 3.598

5.  Evaluating the appropriate use of piperacillin/tazobactam in a community health system: a retrospective chart review.

Authors:  Punit J Shah; Kristi L Ryzner
Journal:  P T       Date:  2013-08

6.  Prospective drug utilization evaluation of three broad-spectrum antimicrobials: cefepime, piperacillin-tazobactam and meropenem.

Authors:  D Raveh; E Muallem-Zilcha; A Greenberg; Y Wiener-Well; Y Schlesinger; A M Yinnon
Journal:  QJM       Date:  2006-05-08

7.  Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

Authors:  Alison G Freifeld; Eric J Bow; Kent A Sepkowitz; Michael J Boeckh; James I Ito; Craig A Mullen; Issam I Raad; Kenneth V Rolston; Jo-Anne H Young; John R Wingard
Journal:  Clin Infect Dis       Date:  2011-02-15       Impact factor: 9.079

Review 8.  The use of piperacillin-tazobactam in neonatal and paediatric patients.

Authors:  Maria F Wolf; Arne Simon
Journal:  Expert Opin Drug Metab Toxicol       Date:  2009-01       Impact factor: 4.481

Review 9.  Piperacillin-tazobactam: a beta-lactam/beta-lactamase inhibitor combination.

Authors:  Alfred Gin; Leanne Dilay; James A Karlowsky; Andrew Walkty; Ethan Rubinstein; George G Zhanel
Journal:  Expert Rev Anti Infect Ther       Date:  2007-06       Impact factor: 5.091

10.  Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America.

Authors:  Joseph S Solomkin; John E Mazuski; John S Bradley; Keith A Rodvold; Ellie J C Goldstein; Ellen J Baron; Patrick J O'Neill; Anthony W Chow; E Patchen Dellinger; Soumitra R Eachempati; Sherwood Gorbach; Mary Hilfiker; Addison K May; Avery B Nathens; Robert G Sawyer; John G Bartlett
Journal:  Surg Infect (Larchmt)       Date:  2010-02       Impact factor: 2.150
View more
  3 in total

1.  Pediatric Antimicrobial Stewardship Programs.

Authors:  Kristen Nichols; Sylvia Stoffella; Rachel Meyers; Jennifer Girotto
Journal:  J Pediatr Pharmacol Ther       Date:  2017 Jan-Feb

2.  Evaluating the appropriateness of carbapenem and piperacillin-tazobactam prescribing in a tertiary care hospital in Saudi Arabia.

Authors:  Nada A Alsaleh; Hussain A Al-Omar; Ahmed Y Mayet; Alexander B Mullen
Journal:  Saudi Pharm J       Date:  2020-09-25       Impact factor: 4.330

3.  Retrospective audit of antibiotic use in a university general pediatrics department using hospital pharmacy dispensing data.

Authors:  Leonie Egle; Katharina Sauter; Svenja Ockfen; Manfred Haber; Sören Becker; Gudrun Wagenpfeil; Michael Zemlin; Sascha Meyer; Arne Simon
Journal:  GMS Infect Dis       Date:  2021-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.